Tri Locum Partners LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $374 Million distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pfizer Inc with a value of $50.2M, Teva Pharmaceutical Industries LTD with a value of $49.7M, Natera, Inc. with a value of $40.3M, Stevanato Group S.P.A. with a value of $37.4M, and Argenx Se with a value of $33.9M.

Examining the 13F form we can see an decrease of $12.8M in the current position value, from $387M to 374M.

Tri Locum Partners LP is based out at New York, NY

Below you can find more details about Tri Locum Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $374 Million
Healthcare: $374 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $374 Million
  • Prior Value $387 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 3 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.